Maarten Arends

2.2k total citations
18 papers, 1.5k citations indexed

About

Maarten Arends is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Maarten Arends has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 7 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Maarten Arends's work include Lysosomal Storage Disorders Research (10 papers), Trypanosoma species research and implications (6 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Maarten Arends is often cited by papers focused on Lysosomal Storage Disorders Research (10 papers), Trypanosoma species research and implications (6 papers) and Carbohydrate Chemistry and Synthesis (5 papers). Maarten Arends collaborates with scholars based in Netherlands, United Kingdom and Canada. Maarten Arends's co-authors include Carla E. M. Hollak, Marieke Biegstraaten, Anneke I. den Hollander, Frans P.M. Cremers, Atul Mehta, Derralynn Hughes, Marijke N. Zonneveld, Robert K. Koenekoop, Klaus Rohrschneider and Christoph Wanner and has published in prestigious journals such as PLoS ONE, Stroke and Journal of the American Society of Nephrology.

In The Last Decade

Maarten Arends

18 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maarten Arends Netherlands 13 783 664 348 340 306 18 1.5k
Suma P. Shankar United States 21 833 1.1× 628 0.9× 282 0.8× 282 0.8× 180 0.6× 71 1.5k
Mark D. Ludman Canada 20 446 0.6× 332 0.5× 173 0.5× 120 0.4× 386 1.3× 41 1.2k
Maila Penttinen Finland 19 383 0.5× 264 0.4× 98 0.3× 128 0.4× 173 0.6× 31 920
Pilar Villacampa Spain 13 344 0.4× 291 0.4× 104 0.3× 130 0.4× 200 0.7× 21 762
Hagit Baris Israel 17 385 0.5× 327 0.5× 163 0.5× 156 0.5× 203 0.7× 49 965
Sheela Nampoothiri India 21 917 1.2× 183 0.3× 251 0.7× 99 0.3× 763 2.5× 125 1.7k
Yves Sznajer Belgium 19 623 0.8× 156 0.2× 134 0.4× 106 0.3× 373 1.2× 50 1.1k
Raymond T. Ferri United States 7 147 0.2× 342 0.5× 116 0.3× 100 0.3× 33 0.1× 8 628
Ariana Kariminejad Iran 21 756 1.0× 64 0.1× 284 0.8× 79 0.2× 715 2.3× 100 1.5k
Sumita Danda India 16 489 0.6× 196 0.3× 111 0.3× 108 0.3× 269 0.9× 122 1.0k

Countries citing papers authored by Maarten Arends

Since Specialization
Citations

This map shows the geographic impact of Maarten Arends's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maarten Arends with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maarten Arends more than expected).

Fields of papers citing papers by Maarten Arends

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maarten Arends. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maarten Arends. The network helps show where Maarten Arends may publish in the future.

Co-authorship network of co-authors of Maarten Arends

This figure shows the co-authorship network connecting the top 25 collaborators of Maarten Arends. A scholar is included among the top collaborators of Maarten Arends based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maarten Arends. Maarten Arends is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Arends, Maarten, Marieke Biegstraaten, Christoph Wanner, et al.. (2018). Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study. Journal of Medical Genetics. 55(5). 351–358. 81 indexed citations
2.
Hollak, Carla E. M., Maarten Arends, Christoph Wanner, et al.. (2018). Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: An international cohort study. Molecular Genetics and Metabolism. 123(2). S64–S65. 1 indexed citations
3.
Arends, Maarten, et al.. (2018). Adaptive pathway development for Fabry disease: a clinical approach. Drug Discovery Today. 23(6). 1251–1257. 7 indexed citations
4.
Arends, Maarten, Frits A. Wijburg, Christoph Wanner, et al.. (2017). Favourable effect of early versus late start of enzyme replacement therapy on plasma globotriaosylsphingosine levels in men with classical Fabry disease. Molecular Genetics and Metabolism. 121(2). 157–161. 66 indexed citations
5.
Arends, Maarten, Marieke Biegstraaten, Derralynn Hughes, et al.. (2017). Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors. PLoS ONE. 12(8). e0182379–e0182379. 87 indexed citations
6.
Arends, Maarten, et al.. (2017). Phenotype, disease severity and pain are major determinants of quality of life in Fabry disease: results from a large multicenter cohort study. Journal of Inherited Metabolic Disease. 41(1). 141–149. 33 indexed citations
7.
Arends, Maarten, Christoph Wanner, Derralynn Hughes, et al.. (2016). Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study. Journal of the American Society of Nephrology. 28(5). 1631–1641. 266 indexed citations
8.
Arends, Maarten, Gabor E. Linthorst, Carla E. M. Hollak, & Marieke Biegstraaten. (2015). Discontinuation of enzyme replacement therapy in Fabry disease in the Dutch cohort. Molecular Genetics and Metabolism. 117(2). 194–198. 8 indexed citations
9.
Arends, Maarten, Carla E. M. Hollak, & Marieke Biegstraaten. (2015). Quality of life in patients with Fabry disease: a systematic review of the literature. Orphanet Journal of Rare Diseases. 10(1). 77–77. 68 indexed citations
10.
Arends, Maarten, Laura van Dussen, Marieke Biegstraaten, & Carla E. M. Hollak. (2013). Malignancies and monoclonal gammopathy in Gaucher disease; a systematic review of the literature. British Journal of Haematology. 161(6). 832–842. 81 indexed citations
11.
Sessa, Alessandro, Anneke I. den Hollander, Maarten Arends, et al.. (2007). FERM protein EPB41L5 is a novel member of the mammalian CRB–MPP5 polarity complex. Experimental Cell Research. 313(19). 3959–3970. 54 indexed citations
12.
Hollander, Anneke I. den, Irma López, Suzanne Yzer, et al.. (2007). Identification of Novel Mutations in Patients with Leber Congenital Amaurosis and Juvenile RP by Genome-wide Homozygosity Mapping with SNP Microarrays. Investigative Ophthalmology & Visual Science. 48(12). 5690–5690. 76 indexed citations
13.
Hollander, Anneke I. den, Robert K. Koenekoop, Suzanne Yzer, et al.. (2006). Mutations in the CEP290 (NPHP6) Gene Are a Frequent Cause of Leber Congenital Amaurosis. The American Journal of Human Genetics. 79(3). 556–561. 488 indexed citations
14.
Hurk, José A. J. M. van den, Penny Rashbass, Ronald Roepman, et al.. (2005). Characterization of the Crumbs homolog 2 (CRB2) gene and analysis of its role in retinitis pigmentosa and Leber congenital amaurosis.. PubMed. 11. 263–73. 80 indexed citations
15.
Gilligan, Amanda, Romesh Markus, Stephen Read, et al.. (2002). Baseline Blood Pressure but Not Early Computed Tomography Changes Predicts Major Hemorrhage After Streptokinase in Acute Ischemic Stroke. Stroke. 33(9). 2236–2242. 73 indexed citations
16.
Broekhuyse, R.M., J. H. Schuurmans Stekhoven, & Maarten Arends. (1991). Experimental autoimmune retinitis in the rat induced by immunization with rhodopsin: An ultrastructural study. Experimental Eye Research. 53(2). 141–149. 6 indexed citations
17.
Boerbooms, A M, et al.. (1991). Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.. Annals of the Rheumatic Diseases. 50(9). 611–618. 66 indexed citations
18.
Jongbloet, P.H., et al.. (1971). An Investigation into the Occurrence of Overripeness Ovopathy in the Normal Population. PubMed. 38(8). 47–61. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suma P. Shankar Breakdown of academic impact, for papers by Mark D. Ludman Breakdown of academic impact, for papers by Maila Penttinen Breakdown of academic impact, for papers by Pilar Villacampa Breakdown of academic impact, for papers by Hagit Baris Breakdown of academic impact, for papers by Sheela Nampoothiri Breakdown of academic impact, for papers by Yves Sznajer Breakdown of academic impact, for papers by Raymond T. Ferri Breakdown of academic impact, for papers by Ariana Kariminejad Breakdown of academic impact, for papers by Sumita Danda
Rankless by CCL
2026